Talk:Prostacyclin

This is the talk page for discussing improvements to the Prostacyclin article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Medicine Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Chemicals Low‑importance

	This article is within the scope of WikiProject Chemicals, a daughter project of WikiProject Chemistry, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this article or visit the project page for details on the project.ChemicalsWikipedia:WikiProject ChemicalsTemplate:WikiProject Chemicalschemicals articles
Low	This article has been rated as Low-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Prostacyclin.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Mode of action HTML entity

As of Thursday February 6, 2014 there is "near" HTML entity in the Mode of action table - &earr;

It's likely supposed to be an up or down but I do not know which.

Untitled

I think there is a wrong structure for prostacyclin!

What do you think it should be? The structure here seems to be in agreement with, e.g. [1] David.Throop 17:53, 2 January 2007 (UTC)[reply]

Please check the structure of prostacyclin, again. It's formula is C20H32O5, but there are 21 Carbon in the structure showed in this website. Is there something wrong? If the structure is correct, the formula should be wrong. I think the formula is correct.

OK, you're right. I have put in a request for a corrected picture.David.Throop 16:46, 8 January 2007 (UTC)[reply]

Good job and thanks.

John Vane's photo

I moved photo of Vane to his bio, where it seemed more appropriate. Eperotao (talk) 23:15, 25 July 2009 (UTC)[reply]

Sources for article content

Would you kindly let me know where the content of this page comes from? I see the diagram was drawn by jdfwolff. This is not a source I can quote or talk about to others if I don't know how the diagram was conceived of in the first place. Thank you. 75.24.118.130 (talk) 18:25, 21 September 2009 (UTC)Scott Kozak75.24.118.130 (talk) 18:25, 21 September 2009 (UTC)[reply]

History - Last paragraph

I think the Lucy Clapp paragraph ought to be removed on the basis that it has no bearing on the history of (discovery of) prostacyclin and it cherry-picks a (very minor) scientific fact about prostacyclin from a very large body of literature.
I noted that this identical paragraph is present on the Treprostinil wiki page as well. Thanks, -david —Preceding unsigned comment added by Das312 (talk • contribs) 17:36, 23 May 2011 (UTC)[reply]

Agreed. I've deleted the para. Possible we could use " treprostinil activates PPARs, another mechanism that contributes to the anti-growth benefits of the prostacyclin class." somewhere in the article if we had a source. - Rod57 (talk) 03:31, 29 December 2015 (UTC)[reply]

"Effective" vasodilator

What's the difference between "effective vasodilator" and "vasodilator"? Is it like angiotensin, and classified as a "potent vasodilator"? 129.180.1.214 (talk) 13:18, 7 April 2013 (UTC)[reply]

Members section and table

Should we call this Variations and analogues ? and explain the Class column on the right ? - Rod57 (talk) 03:16, 29 December 2015 (UTC)[reply]

Check half-life

Hi,

The half-life of prostacyclin is stated here to be 42 seconds. However, many articles put it around 3 to 10 minutes (see Sinzinger & Weber, 1988; Polterauer, Sinzinger & Peskar, 1986, cited below). Also, the source quoted there [5] relates to the half-life of PGE1 and E0 (?). Maybe I'm just missing something and they are the same? It would be nice if OP could clear up the discrepancy.

Sinzinger, H. and Weber, G., 1988. Reduced biological half-life of plasma prostacyclin in pre-eclampsia. Archives of gynecology and obstetrics, 243(4), pp.187-190.

Polterauer, P., Sinzinger, H. and Peskar, B.A., 1986. Biological half-life of prostacyclin and 6-oxo-PGF1α levels in plasma of patients with colonic cancer. Prostaglandins, Leukotrienes and Medicine, 22(3), pp.249-258.

Thanks and best regards 95.148.60.110 (talk) 18:04, 11 April 2020 (UTC)[reply]